BE871769A - Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant - Google Patents

Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant

Info

Publication number
BE871769A
BE871769A BE191542A BE191542A BE871769A BE 871769 A BE871769 A BE 871769A BE 191542 A BE191542 A BE 191542A BE 191542 A BE191542 A BE 191542A BE 871769 A BE871769 A BE 871769A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
composition containing
production process
quinazoline derivatives
quinazoline
Prior art date
Application number
BE191542A
Other languages
English (en)
French (fr)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE871769A publication Critical patent/BE871769A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
BE191542A 1977-11-03 1978-11-03 Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant BE871769A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4566977 1977-11-03

Publications (1)

Publication Number Publication Date
BE871769A true BE871769A (fr) 1979-05-03

Family

ID=10438111

Family Applications (1)

Application Number Title Priority Date Filing Date
BE191542A BE871769A (fr) 1977-11-03 1978-11-03 Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant

Country Status (24)

Country Link
US (1) US4188391A (da)
JP (1) JPS5498786A (da)
AR (2) AR221851A1 (da)
AT (1) AT366043B (da)
AU (1) AU506317B2 (da)
BE (1) BE871769A (da)
CA (1) CA1086735A (da)
CH (1) CH637130A5 (da)
DE (1) DE2847622A1 (da)
DK (1) DK488078A (da)
ES (2) ES474763A1 (da)
FI (1) FI63934C (da)
FR (1) FR2407926A1 (da)
HK (1) HK94184A (da)
IE (1) IE47996B1 (da)
IL (1) IL55845A (da)
IT (1) IT1101287B (da)
KE (1) KE3351A (da)
LU (1) LU80461A1 (da)
MY (1) MY8500284A (da)
NL (1) NL174144C (da)
PH (1) PH14693A (da)
PT (1) PT68733A (da)
SE (1) SE7811323L (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
EP0669324A4 (en) * 1993-09-10 1996-04-03 Eisai Co Ltd CHINAZOLIN DERIVATIVES.
JP4028894B2 (ja) 1996-08-09 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 ベンゾピペリジン誘導体
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2007223036A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2026813A2 (en) * 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) * 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
SG172744A1 (en) * 2006-10-06 2011-07-28 Bausch & Lomb Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
US11407729B2 (en) * 2019-03-19 2022-08-09 Stingray Therapeutics, Inc. Quinoline and quinazoline compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812127A (en) * 1966-10-31 1974-05-21 Pfizer 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
HK94184A (en) 1984-12-07
FI63934B (fi) 1983-05-31
US4188391A (en) 1980-02-12
MY8500284A (en) 1985-12-31
ES474763A1 (es) 1980-12-16
ES480053A1 (es) 1980-07-16
IL55845A0 (en) 1979-01-31
FR2407926B1 (da) 1982-11-12
AR221251A1 (es) 1981-01-15
SE7811323L (sv) 1979-05-04
AU506317B2 (en) 1979-12-20
AR221851A1 (es) 1981-03-31
CH637130A5 (de) 1983-07-15
ATA783878A (de) 1981-07-15
FI63934C (fi) 1983-09-12
JPS566428B2 (da) 1981-02-10
DK488078A (da) 1979-05-04
CA1086735A (en) 1980-09-30
NL7810865A (nl) 1979-05-07
FI783325A (fi) 1979-05-04
IT1101287B (it) 1985-09-28
PT68733A (en) 1978-12-01
NL174144B (nl) 1983-12-01
AT366043B (de) 1982-03-10
LU80461A1 (fr) 1980-05-07
JPS5498786A (en) 1979-08-03
KE3351A (en) 1983-12-16
IT7829368A0 (it) 1978-11-02
DE2847622A1 (de) 1979-05-31
IE47996B1 (en) 1984-08-22
NL174144C (nl) 1984-05-01
IL55845A (en) 1982-07-30
FR2407926A1 (fr) 1979-06-01
AU4127778A (en) 1979-05-17
PH14693A (en) 1981-11-10

Similar Documents

Publication Publication Date Title
BE871769A (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
BE880584A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2353530A1 (fr) Nouveaux derives de guanidine, leur procede de preparation et composition pharmaceutique les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2346350A1 (fr) Nouveaux derives de piperazine et de piperidine, leur procede de preparation et les compositions pharmaceutiques les contenant
BE872347A (fr) Amides substitues de l- et dl-phenylglycine, leur procede de production et composition pharmaceutique les contenant
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
BE871770A (fr) Nouveaux derives de phtalazine, leur procede de production et composition pharmaceutique les contenant
FR2510572B1 (fr) Nouvelles thiazolidinediones, leur procede de production et preparation pharmaceutique les contenant
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
BE849012A (fr) Nouveaux derives imidazoliques, leur procede de preparation et composition pharmaceutique les contenant
LU79966A1 (fr) Nouveaux 3-indolyl-tertiobutylaminopropanols,leur procede de production et medicament les contenant
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
BE876297A (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
BE878230A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2333496A2 (fr) Nouveaux derives d'ethanolamine, leur procede de preparation et composition pharmaceutique les contenant
LU79684A1 (fr) Nouveaux trans-5-aryl-2,3,4a,5,9b-hexahydro-1h-pyrido(4,3-b)indoles,leur procede de preparation et composition pharmaceutique les contenant
BE837698A (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et composition pharmaceutique les contenant
FR2303559A1 (fr) Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant
BE871771A (fr) Nouveaux derives de 4-amino-2-(piperazin-1-yl ou homopiperazin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant
FR2463767B1 (fr) Nouveaux derives de cis-4-(3-phenyl-2-methyl-propyl)-2,6-dimethyl-morpholine, leur procede de preparation et medicaments les contenant
BE872023A (fr) Derives de 4-amino-2-piperidinoquinazoline, leur procede de production et composition pharmaceutique les contenant
BE866745A (fr) Nouveaux derives de phenylglycine, leur procede de preparation et composition pharmaceutique les contenant
BE875091A (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER CORP.

Effective date: 19841103